🚀 VC round data is live in beta, check it out!
Innoscripta Valuation Multiples
Discover revenue and EBITDA valuation multiples for Innoscripta
Innoscripta Overview
About Innoscripta
Innoscripta SE is a software company specializing in cloud-based compliance software for research and development. It provides R&D tax incentives consulting.
Founded
2012
HQ
Employees
N/A
Website
Financials (LTM)
EV
$819M
Innoscripta Financials
Innoscripta reported last 12-month revenue of $138M and EBITDA of $83M.
In the same LTM period, Innoscripta generated $138M in gross profit, $83M in EBITDA, and $55M in net income.
Revenue (LTM)
Innoscripta P&L
In the most recent fiscal year, Innoscripta reported revenue of $124M and EBITDA of $76M.
Innoscripta expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $138M | XXX | $124M | XXX | XXX | XXX |
| Gross Profit | $138M | XXX | $91M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 73% | XXX | XXX | XXX |
| EBITDA | $83M | XXX | $76M | XXX | XXX | XXX |
| EBITDA Margin | 60% | XXX | 62% | XXX | XXX | XXX |
| EBIT Margin | 60% | XXX | 61% | XXX | XXX | XXX |
| Net Profit | $55M | XXX | $51M | XXX | XXX | XXX |
| Net Margin | 40% | XXX | 41% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Innoscripta Stock Performance
Innoscripta has current market cap of $859M, and enterprise value of $819M.
Market Cap Evolution
Innoscripta's stock price is $85.90.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $819M | $859M | 3.8% | XXX | XXX | XXX | $5.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialInnoscripta Valuation Multiples
Innoscripta trades at 5.9x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Innoscripta Financial Valuation Multiples
As of April 18, 2026, Innoscripta has market cap of $859M and EV of $819M.
Equity research analysts estimate Innoscripta's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Innoscripta has a P/E ratio of 15.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $859M | XXX | $859M | XXX | XXX | XXX |
| EV (current) | $819M | XXX | $819M | XXX | XXX | XXX |
| EV/Revenue | 5.9x | XXX | 6.6x | XXX | XXX | XXX |
| EV/EBITDA | 9.9x | XXX | 10.8x | XXX | XXX | XXX |
| EV/EBIT | 9.9x | XXX | 10.8x | XXX | XXX | XXX |
| EV/Gross Profit | 5.9x | XXX | 9.0x | XXX | XXX | XXX |
| P/E | 15.5x | XXX | 16.9x | XXX | XXX | XXX |
| EV/FCF | 18.2x | XXX | 17.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Innoscripta Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Innoscripta Margins & Growth Rates
Innoscripta's revenue in the last 12 month grew by 37%.
Innoscripta's rule of 40 is 99% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Innoscripta's rule of X is 161% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Innoscripta Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 37% | XXX | 39% | XXX | XXX | XXX |
| EBITDA Margin | 60% | XXX | 62% | XXX | XXX | XXX |
| EBITDA Growth | 31% | XXX | 31% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 99% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 161% | XXX | XXX | XXX |
| S&M Expenses to Revenue | 19% | XXX | 18% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 15% | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 7% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 13% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Innoscripta Public Comps
See public comps and valuation multiples for other Governance, Risk & Compliance Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Innoscripta | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Innoscripta M&A Activity
Innoscripta acquired XXX companies to date.
Last acquisition by Innoscripta was on XXXXXXXX, XXXXX. Innoscripta acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Innoscripta
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialInnoscripta Investment Activity
Innoscripta invested in XXX companies to date.
Innoscripta made its latest investment on XXXXXXXX, XXXXX. Innoscripta invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Innoscripta
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Innoscripta
| When was Innoscripta founded? | Innoscripta was founded in 2012. |
| Where is Innoscripta headquartered? | Innoscripta is headquartered in Germany. |
| Is Innoscripta publicly listed? | Yes, Innoscripta is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Innoscripta? | Innoscripta trades under 1INN ticker. |
| When did Innoscripta go public? | Innoscripta went public in 2025. |
| Who are competitors of Innoscripta? | Innoscripta main competitors are |
| What is the current market cap of Innoscripta? | Innoscripta's current market cap is $859M. |
| What is the current revenue of Innoscripta? | Innoscripta's last 12 months revenue is $138M. |
| What is the current revenue growth of Innoscripta? | Innoscripta revenue growth (NTM/LTM) is 37%. |
| What is the current EV/Revenue multiple of Innoscripta? | Current revenue multiple of Innoscripta is 5.9x. |
| Is Innoscripta profitable? | Yes, Innoscripta is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Innoscripta? | Innoscripta's last 12 months EBITDA is $83M. |
| What is Innoscripta's EBITDA margin? | Innoscripta's last 12 months EBITDA margin is 60%. |
| What is the current EV/EBITDA multiple of Innoscripta? | Current EBITDA multiple of Innoscripta is 9.9x. |
| What is the current FCF of Innoscripta? | Innoscripta's last 12 months FCF is $45M. |
| What is Innoscripta's FCF margin? | Innoscripta's last 12 months FCF margin is 33%. |
| What is the current EV/FCF multiple of Innoscripta? | Current FCF multiple of Innoscripta is 18.2x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.